Citalopram Hydrobromide Tablet
NDC Package 76282-628-90
Package Information
Citalopram Hydrobromide (citalopram) tablets is citalopram is used to treat depression. This formulation utilizes a tablet delivery system. Marketed by Exelan Pharmaceuticals Inc., this product is identified by NDC 76282-628 and is authorized under FDA application ANDA077534.
Identification & Billing
- RxCUI: 200371 - citalopram 20 MG Oral Tablet
- RxCUI: 200371 - citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet
- RxCUI: 283672 - citalopram 10 MG Oral Tablet
- RxCUI: 283672 - citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet
- RxCUI: 309314 - citalopram 40 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76282 - Exelan Pharmaceuticals Inc.
- 76282-628 - Citalopram Hydrobromide
- 76282-628-90 - 90 TABLET in 1 BOTTLE
- 76282-628 - Citalopram Hydrobromide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (76282-628). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76282-628-90 identifies a specific commercial package of 90 tablet in 1 bottle of Citalopram Hydrobromide, a human prescription drug labeled by Exelan Pharmaceuticals Inc.. This tablet is formulated for oral use and contains citalopram hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Exelan Pharmaceuticals Inc. on November 10, 2017. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Citalopram is used to treat depression. It may improve your energy level and feelings of well-being. Citalopram is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.
How is this Exelan Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76282062890. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.